World Journal of
Pharmaceutical and Life Sciences

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), 

Abstract

CLINICAL EFFICACY OF HABB-E-SURANJAN IN OSTEOARTHRITIS (WAJA-URRIKBAH)

Arsheed Iqbal*, Afroza Jan, Zahood Ahmad, Kounsar Jan

ABSTRACT

Osteoarthritis (OA), also often called „osteoarthrosis or „degenerative joint disease,? is the most common form of arthritis. Prevalence of OA in India is reported to be in the range of 17-60.6%. Knee osteoarthritis (OA) is a common condition which represents a major contribution to the burden of physical disability. Prevalence increases with age, so that about 11% of all women over the age of 60 years have symptoms due to knee OA. Habb-e- Suranjan is a Unani poly herbal compound formulation mentioned in a Unani pharmacopeia, Qarabadeen-e- Majeedi. In which it is recommended for waja-ul-mafasil (arthralgia). This formulation contains three ingredients, Chob Zard (Curcuma longa Linn.), Surinjan Talkh (Colchium luteum Baker.) and Samaghe Arabi (Acacia Arabica Willd.). Aim of this study was to comprehend the effectiveness of the drug Habb-e-Suranjan in knee osteoarthritis patients. This study was done in 25 patients. Habb-e-Suranjan was administered orally as 2 pills 2 times a day with water or milk for one month. The outcome measures such as VAS (Visual Analogue Scale), KOOS (Knee injury and Osteoarthritis Outcome Score) and 10 meters walking test were used to assess the symptoms before and after treatment. These paired data were analyzed statistically according to Wilcoxon Matched paired signed rank test. KOOS mean pain score was50.4 ± 4.39 before treatment and it was68.13±2.21 after treatment with an extremely significant improvement. Similarly there was a significant (42.14**±4.45) improvement at 4th week in KOOS symptoms score.

[Full Text Article]

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue
Dr. Olajide Adedayo Ajayi

Download Article : Click here